Literature DB >> 19650142

Identification of Chlamydia trachomatis in a patient with ocular lymphoma.

Carlo Contini, Silva Seraceni, Silvia Carradori, Rosario Cultrera, Paolo Perri, Francesco Lanza.   

Abstract

Accumulating evidence suggests that infectious agents may play a role in ocular adnexa lymphomas (OALs) of MALT-type [1-4]. In particular, Chlamydia psittaci, the causative agent of psittacosis, has been detected by PCR in most patients from Italy or isolated eastern Asiatic countries with OALs in absence of other Chlamydia species [4-8]. These patients have also been shown to have a complete or partial response to doxycycline, recognized to be a cheap and safe treatment in these patients [5,6]. In contrast, OAL patients from other geographic areas and with different genetic background were found to be negative for C. psittaci DNA or had a quite variable response to antibiotic treatment, assuming that this pathogen might not play a ubiquitous role in OALs and that bacterial infection is not associated with OAL [8-12].

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650142     DOI: 10.1002/ajh.21477

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Detection of Chlamydophila pneumoniae and human herpesvirus 8 in primary cutaneous anaplastic large-cell lymphoma: a case report.

Authors:  Alessandro Borghi; Elisabetta Caselli; Dario Di Luca; Adolfo Sebastiani; Paolo Perri; Silva Seraceni; Carlo Contini; Annarosa Virgili
Journal:  Infect Agent Cancer       Date:  2013-10-07       Impact factor: 2.965

2.  Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection.

Authors:  Elisabetta Caselli; Alessandro Borghi; Martina Maritati; Roberta Gafà; Giovanni Lanza; Dario Di Luca; Annarosa Virgili; Carlo Contini
Journal:  Infect Agent Cancer       Date:  2016-07-05       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.